These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19769359)

  • 1. Predictions of binding for dopamine D2 receptor antagonists by the SIE method.
    Wang YT; Su ZY; Hsieh CH; Chen CL
    J Chem Inf Model; 2009 Oct; 49(10):2369-75. PubMed ID: 19769359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of binding residues between scorpion neurotoxins and D2 dopamine receptor: a computational docking study.
    Sudandiradoss C; George Priya Doss C; Rajasekaran R; Purohit R; Ramanathan K; Sethumadhavan R
    Comput Biol Med; 2008 Oct; 38(10):1056-67. PubMed ID: 18799158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling the similarity and divergence of dopamine D2-like receptors and identification of validated ligand-receptor complexes.
    Boeckler F; Lanig H; Gmeiner P
    J Med Chem; 2005 Feb; 48(3):694-709. PubMed ID: 15689154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studying the catechol binding cavity in comparative models of human dopamine D2 receptor.
    Sakhteman A; Lahtela-Kakkonen M; Poso A
    J Mol Graph Model; 2011 Feb; 29(5):685-92. PubMed ID: 21168353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Searching the "biologically relevant"conformation of dopamine: a computational approach.
    Andujar SA; Tosso RD; Suvire FD; Angelina E; Peruchena N; Cabedo N; Cortes D; Enriz RD
    J Chem Inf Model; 2012 Jan; 52(1):99-112. PubMed ID: 22146008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, binding affinity, and molecular docking analysis of new benzofuranone derivatives as potential antipsychotics.
    Aranda R; Villalba K; Raviña E; Masaguer CF; Brea J; Areias F; Domínguez E; Selent J; López L; Sanz F; Pastor M; Loza MI
    J Med Chem; 2008 Oct; 51(19):6085-94. PubMed ID: 18783204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A theoretical study to investigate D2DAR/D4DAR selectivity: receptor modeling and molecular docking of dopaminergic ligands.
    Ortore G; Tuccinardi T; Bertini S; Martinelli A
    J Med Chem; 2006 Feb; 49(4):1397-407. PubMed ID: 16480275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IKKbeta inhibitors identification part I: homology model assisted structure based virtual screening.
    Nagarajan S; Doddareddy Mr; Choo H; Cho YS; Oh KS; Lee BH; Pae AN
    Bioorg Med Chem; 2009 Apr; 17(7):2759-66. PubMed ID: 19285872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular modeling and docking study on dopamine D2-like and serotonin 5-HT2A receptors.
    Duan X; Zhang M; Zhang X; Wang F; Lei M
    J Mol Graph Model; 2015 Apr; 57():143-55. PubMed ID: 25728902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theoretical study of 3-D molecular similarity and ligand binding modes of orthologous human and rat D2 dopamine receptors.
    Soriano-Ursúa MA; Ocampo-López JO; Ocampo-Mendoza K; Trujillo-Ferrara JG; Correa-Basurto J
    Comput Biol Med; 2011 Jul; 41(7):537-45. PubMed ID: 21621758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigations on the interactions of scorpion neurotoxins with the predicted structure of D1 dopamine receptor by protein-protein docking method. A bioinformatics approach.
    Sudandiradoss C; Priya Doss CG; Rajasekaran R; Ramanathan K; Purohit R; Sethumadhavan R
    C R Biol; 2008 Jul; 331(7):489-99. PubMed ID: 18558372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the structural basis and atomistic binding mechanistic of the selective antagonist blockade at D
    Appiah-Kubi P; Olotu FA; Soliman MES
    J Mol Recognit; 2021 May; 34(5):e2885. PubMed ID: 33401335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, dopamine D2 receptor binding studies and docking analysis of 5-[3-(4-arylpiperazin-1-yl)propyl]-1H-benzimidazole, 5-[2-(4-arylpiperazin-1-yl)ethoxy]-1H-benzimidazole and their analogs.
    Sukalović V; Andrić D; Roglić G; Kostić-Rajacić S; Schrattenholz A; Soskić V
    Eur J Med Chem; 2005 May; 40(5):481-93. PubMed ID: 15893022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine D2, D3, and D4 selective phenylpiperazines as molecular probes to explore the origins of subtype specific receptor binding.
    Ehrlich K; Götz A; Bollinger S; Tschammer N; Bettinetti L; Härterich S; Hübner H; Lanig H; Gmeiner P
    J Med Chem; 2009 Aug; 52(15):4923-35. PubMed ID: 19606869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational modeling toward understanding agonist binding on dopamine 3.
    Zhao Y; Lu X; Yang CY; Huang Z; Fu W; Hou T; Zhang J
    J Chem Inf Model; 2010 Sep; 50(9):1633-43. PubMed ID: 20695484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding mode analyses and pharmacophore model development for sulfonamide chalcone derivatives, a new class of alpha-glucosidase inhibitors.
    Bharatham K; Bharatham N; Park KH; Lee KW
    J Mol Graph Model; 2008 Jun; 26(8):1202-12. PubMed ID: 18096420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the Glutamate Agonist LY404,039 Binding to Nonstatic Dopamine Receptor D2 Dimer Structures and Consensus Docking.
    Salmas RE; Seeman P; Aksoydan B; Erol I; Kantarcioglu I; Stein M; Yurtsever M; Durdagi S
    ACS Chem Neurosci; 2017 Jun; 8(6):1404-1415. PubMed ID: 28272861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atomistic molecular dynamics simulations of typical and atypical antipsychotic drugs at the dopamine D2 receptor (D2R) elucidates their inhibition mechanism.
    Salmas RE; Yurtsever M; Durdagi S
    J Biomol Struct Dyn; 2017 Mar; 35(4):738-754. PubMed ID: 26923489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine/serotonin receptor ligands. Part 17: a cross-target SAR approach: affinities of azecine-styled ligands for 5-HT(2A) versus D1 and D2 receptors.
    Enzensperger C; Görnemann T; Pertz HH; Lehmann J
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3809-13. PubMed ID: 18534847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating the differential activation of vascular endothelial growth factor (VEGF) receptors.
    Horta BA; Sodero AC; de Alencastro RB
    J Mol Graph Model; 2009 Oct; 28(3):287-96. PubMed ID: 19734078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.